Identity
- Trade Name
- WELL-LIFE FDA UDI
- Generic Name
- Physical therapy transcutaneous electrical stimulation system, line-powered FDA UDI
- Device Name
- Well-Life Powered Muscle Stimulator , analog type. Intended for: • Relax muscle spasms • Prevent or retard disuse atrophy • Increase local blood circulation • Re-educate muscles • Maintain or increase the range of motion FDA UDI
- Model / Reference
- WL-2104 FDA UDI
- Description
- Well-Life Powered Muscle Stimulator , analog type. Intended for: • Relax muscle spasms • Prevent or retard disuse atrophy • Increase local blood circulation • Re-educate muscles • Maintain or increase the range of motion FDA UDI
Identifiers
- Primary DI / UDI-DI
- 04719872261049 FDA UDI
- 510(k) Number
- K013768 FDA UDI
- FDA Product Code
- LIH FDA UDI
- GMDN Term
- Physical therapy transcutaneous electrical stimulation system, line-powered FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 882.5890 FDA UDI
- Commercial Distribution
- Not in Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
Yes
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
No
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
No
FDA UDI
MR Safe FDA UDI
Well-Life by Well-Life Healthcare, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Well-Life Healthcare, Inc.
Sources (1)
- FDA UDI e38201d2-8e46-40c6-97bb-40cbca60ef17 35 fields · synced May 30, 2026